单侧椎体成形术联合唑来膦酸治疗老年骨质疏松性椎体压缩骨折的短期疗效(4)
[9] Liang B C，Shi Z Y，Wang B，et al.Intravenous Zoledronic Acid 5 mg on Bone Turnover Markers and Bone Mineral Density in East China Subjects with Newly Diagnosed Osteoporosis：A 24-month Clinical Study[J].Orthopaedic Surgery，2017，9(1)：103-109.
[10]许士璐，王芳，李招霞，等.密固达治疗绝经后骨质疏松患者的3年临床分析[J].中国骨质疏松杂志，2017，23(8)：1071-1074.
[11]李佩芳，宁宁.唑来膦酸注射液治疗骨质疏松症的研究进展[J].华西药学杂志，2016，31(4)：436-438.
[12] Wang G，Sui L，Gai P，et al.The efficacy and safety of vertebral fracture prevention therapies in post-menopausal osteoporosis treatment：Which therapies work best？ a network meta-analysis[J].Bone & Joint Research，2017，6(7)：452-463.
[13] Hsieh P C.Effectiveness and Safety of Zoledronic Acid in the Treatment of Osteoporosis[J].Orthopedics，2016，39(2)：e263-270.
[14] Nakamura T，Fukunaga M，Nakano T，et al.Efficacy and safety of once-yearly zoledronic acid in Japanese patients with primary osteoporosis：two-year results from a randomized placebo-controlled double-blind study(ZOledroNate treatment in Efficacy to osteoporosis;ZONE study)[J].Osteoporosis International，2017，28(1)：1-10.
(收稿日期：2018-06-27) (本文編辑：周亚杰), 百拇医药(马超 魏金栋 武永东)
[10]许士璐，王芳，李招霞，等.密固达治疗绝经后骨质疏松患者的3年临床分析[J].中国骨质疏松杂志，2017，23(8)：1071-1074.
[11]李佩芳，宁宁.唑来膦酸注射液治疗骨质疏松症的研究进展[J].华西药学杂志，2016，31(4)：436-438.
[12] Wang G，Sui L，Gai P，et al.The efficacy and safety of vertebral fracture prevention therapies in post-menopausal osteoporosis treatment：Which therapies work best？ a network meta-analysis[J].Bone & Joint Research，2017，6(7)：452-463.
[13] Hsieh P C.Effectiveness and Safety of Zoledronic Acid in the Treatment of Osteoporosis[J].Orthopedics，2016，39(2)：e263-270.
[14] Nakamura T，Fukunaga M，Nakano T，et al.Efficacy and safety of once-yearly zoledronic acid in Japanese patients with primary osteoporosis：two-year results from a randomized placebo-controlled double-blind study(ZOledroNate treatment in Efficacy to osteoporosis;ZONE study)[J].Osteoporosis International，2017，28(1)：1-10.
(收稿日期：2018-06-27) (本文編辑：周亚杰), 百拇医药(马超 魏金栋 武永东)